These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3460522)

  • 1. Effect of imipenem-cilastatin therapy on fecal flora.
    Welkon CJ; Long SS; Gilligan PH
    Antimicrob Agents Chemother; 1986 May; 29(5):741-3. PubMed ID: 3460522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of imipenem/cilastatin on the colonic microflora.
    Nord CE; Kager L; Philipson A; Stiernstedt G
    Rev Infect Dis; 1985; 7 Suppl 3():S432-4. PubMed ID: 3863218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
    Baruchel A; Hartmann O; Andremont A; Tancrède C
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem-cilastatin: the first thienamycin antibiotic.
    Jacobs RF
    Pediatr Infect Dis; 1986; 5(4):444-8. PubMed ID: 3523460
    [No Abstract]   [Full Text] [Related]  

  • 5. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
    Calandra GB; Hesney M; Grad C
    Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early clinical experience with imipenem-cilistatin.
    Ellis-Pegler RB; Downey D; Bremner DA
    N Z Med J; 1985 Mar; 98(775):188-91. PubMed ID: 3856762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
    Reutter FW
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem-cilastatin sodium (Primaxin).
    Med Lett Drugs Ther; 1986 Mar; 28(709):29-31. PubMed ID: 3512968
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
    Calandra GB; Ricci FM; Wang C; Brown KR
    J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
    Garau J; Casagrán A; Sánchez C; Matas E
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem/cilastatin for the treatment of infections in hospitalized children.
    Alpert G; Dagan R; Connor E; Campos JM; Bloh AM; Powell KR; Plotkin SA
    Am J Dis Child; 1985 Nov; 139(11):1153-6. PubMed ID: 3904406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of imipenem/cilastatin on the aerobic faecal flora of children.
    Borderon JC; Rastegar A; Laugier J; Gold F
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():121-5. PubMed ID: 3102450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of imipenem/cilastatin therapy on faecal flora.
    Nord CE; Kager L; Philipson A; Stiernstedt G
    Eur J Clin Microbiol; 1984 Oct; 3(5):475-7. PubMed ID: 6594237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem/cilastatin as secondary therapy for infections in cancer patients.
    Bodey GP; Rolston K; Jones P; Alvarez ME; Fainstein V; Steelhammer L
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():161-6. PubMed ID: 3469189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of imipenem/cilastatin therapy on normal fecal flora.
    Wexler HM; Finegold SM
    Am J Med; 1985 Jun; 78(6A):41-6. PubMed ID: 3859214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.
    Lode H; Wiley R; Höffken G; Wagner J; Borner K
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1491-6. PubMed ID: 3324956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR; Hart CB; Shih WJ; Aziz MA
    Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections.
    Fan W; del Busto R; Love M; Markowitz N; Cendrowski C; Cardenas J; Quinn E; Saravolatz L
    Antimicrob Agents Chemother; 1986 Jan; 29(1):26-9. PubMed ID: 3460521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.